Interestingly, when we assessed whether CSF–PS1 levels are altered in AD, ventricular post-mortem samples (disease at term) display higher levels of PS1 than those present in non-demented control cases, particularly the stable complexes resolved by sucrose density gradients. Here, PSEN1 is linked to Alzheimer disease.